The Significance of Psychological Support in Managing Depression in Parkinson's Disease: Combining Venlafaxine with Pramipexole and Psychological Care. [PDF]
Huang Z +5 more
europepmc +1 more source
Physicochemical profiling and ranking of parkinson's disease drugs through QSPR and Fuzzy TOPSIS analysis. [PDF]
Chen Y +5 more
europepmc +1 more source
Comparing Parkinson's Disease Medications Categorised by Location in New South Wales, Australia: Linking the 45 and Up Study and the Pharmaceutical Benefits Scheme (PBS) Data. [PDF]
Logan PA +4 more
europepmc +1 more source
Parkinson disease treatments on national essential medicines lists, African Region. [PDF]
Fothergill-Misbah N +7 more
europepmc +1 more source
Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant. [PDF]
Usnich T +4 more
europepmc +1 more source
Cortical Effects of Dopamine Replacement Account for Clinical Response Variability in Parkinson's Disease. [PDF]
Wiesman AI +5 more
europepmc +1 more source
Paradoxical Gait Response to Levodopa in Parkin-Gene-Related Early-Onset Parkinson's Disease: Dopa Worsening Dystonia. [PDF]
Mehta A, Naheed D, Tan LCS, Neo S.
europepmc +1 more source
Impulse control disorders in Parkinson's disease: a national Swedish registry study on high-risk treatments and vulnerable patient groups. [PDF]
Wolfschlag M +4 more
europepmc +1 more source
Real-world evidence of constipation and laxative use in the Korean population with chronic kidney disease from a common data model. [PDF]
Kim K +7 more
europepmc +1 more source

